of the Foundation Deutsches Krebsforschungszentrum, Heidelberg, with the Ministry of Science and Technology, Israel

Scientific program committee and coordinators

Scientific program committee and coordinators
© dkfz.de

In 1976 the agreement for a cooperational program in cancer research was signed by the Deutsches Krebsforschungszentrum (DKFZ) and, the Israeli National Council for Research and Development (NCRD) – now the Ministry of Science and Technology.

Each of the cooperational joint projects consists of one Israeli and one DKFZ subproject, lasting for a period of three years. Usually 18 joint projects are in operation. The cooperation program is jointly administered by program coordinators from MOST and the DKFZ, and is governed by a scientific program committee composed of experts in the cancer field from Europe and Israel.

(v.l.n.r.) Prof. Dr. Michael Boutros, Scientific Director (interim) DKFZ, Ofir Akunis, Minister of Science and Technology, Israel, Prof. Dr. Dr. h.c. Otmar D. Wiestler, President of the Helmholtz-Gemeinschaft, Prof. Dr. Josef Puchta, Administrative Director DKFZ.

(v.l.n.r.) Prof. Dr. Michael Boutros, Scientific Director (interim) DKFZ, Ofir Akunis, Minister of Science and Technology, Israel, Prof. Dr. Dr. h.c. Otmar D. Wiestler, President of the Helmholtz-Gemeinschaft, Prof. Dr. Josef Puchta, Administrative Director DKFZ.
© dkfz.de

In March 2016, a symposium was held celebrating the 40th anniversary of the cooperation in Tel Aviv.

From its very beginnings, the cooperation program saw many renowned scientists taking part as principal investigators. One of them, Aaron Ciechanover, has received the Nobel Prize for Chemistry in October 2004, together with Avram Hershko and Irwin Rose. In the early 1980s, these scientists discovered how the human body disposes of proteins that are no longer needed. The molecule ubiquitin plays a key role in this process. From 1998 – 2000, Aaron Ciechanover and Martin Scheffner from the German Cancer Research Center had a joined project entitled: Regulation of cell regulatory proteins by the ubiquitin-dependent proteolytic pathway. This project, among others, was considered an outstanding project, so-called Highlight-Project.

to top